IDiyas

For the Inventor, By the Inventor

Oberwil, Switzerland

Ivan Kompis

USPTO Granted Patents = 24

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal24 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1998

Loading Chart...
24 patents (USPTO):Explore Patents
1. 5721242 - Antibiotic combination (1998-02-24),
2. 5283248 - Amino substituted pyrimido[1,6-2]benzimidazoles (1994-02-01),
3. 4977265 - Quinoline derivatives (1990-12-11),
4. 4946847 - Quinoline derivatives (1990-08-07),
5. 4908470 - Process for the methyl-4-(dimethylamino)-3,5-dimethoxybenzoate (1990-03-13),
6. 4806541 - Quinoline derivatives (1989-02-21),
7. 4792557 - 2,4-diamino-5[4-amino (or dimethylamino)-3,5-dimethoxybenzyl]pyrimidine (1988-12-20),
8. 4774249 - Pyrimidine derivatives for treating malaria (1988-09-27),
9. 4720546 - Intermediates for the preparation of substituted 2-phenyl-1,3-dioxolanes (1988-01-19),
10. 4659818 - Intermediates for benzylpyrimidines (1987-04-21),
11. 4640918 - Substituted 2-phenyl-1,3-dioxolanes (1987-02-03),
12. 4599416 - Process for the preparation of aqueous solutions of potentiated (1986-07-08),
13. 4590270 - 2,4-diamino-[4-piperidinyl]pyrimidines useful as antibacterial agents, (1986-05-20),
14. 4532245 - Pharmaceutical compositions (1985-07-30),
15. 4515948 - 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy (1985-05-07),

Title: Ivan Kompis – Innovator in Pharmaceutical Patents

Introduction

Ivan Kompis, based in Oberwil, Switzerland, is a distinguished inventor with an impressive portfolio of 24 patents. His innovative contributions primarily focus on pharmaceutical formulations aimed at combating various bacterial infections, showcasing his dedication to improving healthcare through scientific advancements.

Latest Patents

Among his latest patents is a groundbreaking antibiotic combination. This invention involves pharmaceutical preparations containing an antibacterially-active synergistic combination of epiroprim and dapsone. This formulation proves useful for the treatment or control of infections caused by pathogens such as mycobacteria, Actinomycetes, and toxoplasmosis. Another notable patent includes amino substituted pyrimido[1,6-2]benzimidazoles, which describes novel substituted pyrimidobenzimidazole derivatives. These compounds exhibit an inhibitory action on the DNA-gyrase activity in bacteria, establishing their potential as preventive measures or treatments for bacterial infections.

Career Highlights

Ivan Kompis is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company allows him to utilize his expertise in developing innovative solutions that address critical health challenges. His vast experience and knowledge have made him a significant contributor to the field of pharmaceutical research and development.

Collaborations

Throughout his career, Ivan has collaborated with notable colleagues such as Guido Zanetti and Gerald Rey-Bellet. These partnerships have enabled him to enhance his research outcomes and contribute to the collective goal of advancing medical science through innovation.

Conclusion

Ivan Kompis stands out as a remarkable inventor whose work has significant implications in the pharmaceutical industry. With a strong focus on developing effective treatments for bacterial infections, his contributions are invaluable. As he continues to innovate and excel, his patents will play a pivotal role in shaping future healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…